Loading…

Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer

Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapie...

Full description

Saved in:
Bibliographic Details
Published in:Cancer control 2024-08, Vol.31, p.10732748241280444
Main Authors: Yu, Alice, Dinckal, Mustafa, Pow-Sang, Julio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713
container_end_page
container_issue
container_start_page 10732748241280444
container_title Cancer control
container_volume 31
creator Yu, Alice
Dinckal, Mustafa
Pow-Sang, Julio
description Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.
doi_str_mv 10.1177/10732748241280444
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2edf5b65b1404c82a15976f434f348c0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_10732748241280444</sage_id><doaj_id>oai_doaj_org_article_2edf5b65b1404c82a15976f434f348c0</doaj_id><sourcerecordid>3101795453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EoqXwA7igSFy4pHhsJ7aP1QraikpUbRFHa-KMt15lk8VOkPj3uGxpJSpOtp6_eTOex9hb4McAWn8ErqXQyggFwnCl1DN2CI1oayEb-7zcy3t9BxywVzlvOBdcSfWSHUgrlIRWHrIv10taR49DddINOMefVN3cUsJdpFzFsbosGo1zrr7H-ba6wj5OifySUhGryzTlGWeqVjh6Sq_Zi4BDpjf35xH79vnTzeqsvvh6er46uah9GWuurQ7IKehAvhNKo--0B-I9iCa0Rhjfa26MLRiXXnKQ1AFC25tgPRgN8oid7337CTdul-IW0y83YXR_hCmtHaY5-oGcoD40Xdt0oLjyRiA0VrehbCFIZTwvXh_2Xrs0_Vgoz24bs6dhwJGmJTsJHLRtVCML-v4fdDMtaSw_LZSyWoMFVSjYU74sJycKDwMCd3epuSeplZp3985Lt6X-oeJvTAU43gMZ1_TY9v-OvwH8Mpzz</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149771914</pqid></control><display><type>article</type><title>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content Database</source><source>Sage Journals GOLD Open Access 2024</source><creator>Yu, Alice ; Dinckal, Mustafa ; Pow-Sang, Julio</creator><creatorcontrib>Yu, Alice ; Dinckal, Mustafa ; Pow-Sang, Julio</creatorcontrib><description>Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.</description><identifier>ISSN: 1073-2748</identifier><identifier>ISSN: 1526-2359</identifier><identifier>EISSN: 1526-2359</identifier><identifier>DOI: 10.1177/10732748241280444</identifier><identifier>PMID: 39243163</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Ablation Techniques - methods ; Cancer therapies ; Disease management ; Humans ; Male ; Neoplasm Recurrence, Local ; Prostate cancer ; Prostatectomy ; Prostatectomy - methods ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - surgery ; Radiation therapy ; Salvage Therapy - methods ; Treatment Outcome</subject><ispartof>Cancer control, 2024-08, Vol.31, p.10732748241280444</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713</cites><orcidid>0000-0001-9815-3619 ; 0000-0003-4905-1602 ; 0000-0003-1827-6585</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/10732748241280444$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3149771914?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>313,314,780,784,792,21964,25751,27851,27920,27922,27923,37010,37011,44588,44943,45331</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39243163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Alice</creatorcontrib><creatorcontrib>Dinckal, Mustafa</creatorcontrib><creatorcontrib>Pow-Sang, Julio</creatorcontrib><title>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</title><title>Cancer control</title><addtitle>Cancer Control</addtitle><description>Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.</description><subject>Ablation Techniques - methods</subject><subject>Cancer therapies</subject><subject>Disease management</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasm Recurrence, Local</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatectomy - methods</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Radiation therapy</subject><subject>Salvage Therapy - methods</subject><subject>Treatment Outcome</subject><issn>1073-2748</issn><issn>1526-2359</issn><issn>1526-2359</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kUFv1DAQhS0EoqXwA7igSFy4pHhsJ7aP1QraikpUbRFHa-KMt15lk8VOkPj3uGxpJSpOtp6_eTOex9hb4McAWn8ErqXQyggFwnCl1DN2CI1oayEb-7zcy3t9BxywVzlvOBdcSfWSHUgrlIRWHrIv10taR49DddINOMefVN3cUsJdpFzFsbosGo1zrr7H-ba6wj5OifySUhGryzTlGWeqVjh6Sq_Zi4BDpjf35xH79vnTzeqsvvh6er46uah9GWuurQ7IKehAvhNKo--0B-I9iCa0Rhjfa26MLRiXXnKQ1AFC25tgPRgN8oid7337CTdul-IW0y83YXR_hCmtHaY5-oGcoD40Xdt0oLjyRiA0VrehbCFIZTwvXh_2Xrs0_Vgoz24bs6dhwJGmJTsJHLRtVCML-v4fdDMtaSw_LZSyWoMFVSjYU74sJycKDwMCd3epuSeplZp3985Lt6X-oeJvTAU43gMZ1_TY9v-OvwH8Mpzz</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Yu, Alice</creator><creator>Dinckal, Mustafa</creator><creator>Pow-Sang, Julio</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9815-3619</orcidid><orcidid>https://orcid.org/0000-0003-4905-1602</orcidid><orcidid>https://orcid.org/0000-0003-1827-6585</orcidid></search><sort><creationdate>20240801</creationdate><title>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</title><author>Yu, Alice ; Dinckal, Mustafa ; Pow-Sang, Julio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Ablation Techniques - methods</topic><topic>Cancer therapies</topic><topic>Disease management</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasm Recurrence, Local</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatectomy - methods</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Radiation therapy</topic><topic>Salvage Therapy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Alice</creatorcontrib><creatorcontrib>Dinckal, Mustafa</creatorcontrib><creatorcontrib>Pow-Sang, Julio</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Alice</au><au>Dinckal, Mustafa</au><au>Pow-Sang, Julio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer</atitle><jtitle>Cancer control</jtitle><addtitle>Cancer Control</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>31</volume><spage>10732748241280444</spage><pages>10732748241280444-</pages><issn>1073-2748</issn><issn>1526-2359</issn><eissn>1526-2359</eissn><abstract>Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>39243163</pmid><doi>10.1177/10732748241280444</doi><orcidid>https://orcid.org/0000-0001-9815-3619</orcidid><orcidid>https://orcid.org/0000-0003-4905-1602</orcidid><orcidid>https://orcid.org/0000-0003-1827-6585</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2748
ispartof Cancer control, 2024-08, Vol.31, p.10732748241280444
issn 1073-2748
1526-2359
1526-2359
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2edf5b65b1404c82a15976f434f348c0
source NCBI_PubMed Central(免费); Publicly Available Content Database; Sage Journals GOLD Open Access 2024
subjects Ablation Techniques - methods
Cancer therapies
Disease management
Humans
Male
Neoplasm Recurrence, Local
Prostate cancer
Prostatectomy
Prostatectomy - methods
Prostatic Neoplasms - radiotherapy
Prostatic Neoplasms - surgery
Radiation therapy
Salvage Therapy - methods
Treatment Outcome
title Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A42%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20Ablative%20Therapies%20in%20Patients%20With%20Radiorecurrent%20Prostate%20Cancer&rft.jtitle=Cancer%20control&rft.au=Yu,%20Alice&rft.date=2024-08-01&rft.volume=31&rft.spage=10732748241280444&rft.pages=10732748241280444-&rft.issn=1073-2748&rft.eissn=1526-2359&rft_id=info:doi/10.1177/10732748241280444&rft_dat=%3Cproquest_doaj_%3E3101795453%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-97fa0ef7fecb247acb7c1e0d125f6828cd7088997f03c3013eb1a16d8f9c18713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3149771914&rft_id=info:pmid/39243163&rft_sage_id=10.1177_10732748241280444&rfr_iscdi=true